Bowel cancer, also known as colorectal cancer, is the second most common cancer in Australian men and women. It affects 1 in 13 people. It is also Australia’s second deadliest cancer, with over 5,000 people dying each year. Early detection through screening can improve survival rates, however further research is needed to help find cures and prevent the disease.
The Bowel Cancer and Biomarker Laboratory at the Kolling Institute uses advanced technologies to study the genes and proteins responsible for bowel cancers growing and spreading. Our aim is to use a patient’s own molecular information to understand the risk of bowel cancer developing and to guide treatment options. As part of our research, we are studying how to control bowel polyp growth, which are precursors to cancer. We are doing this through diet and chemotherapy drugs.
The University of Sydney | Northern Clinical School
Faculty of Medicine and Health
Honorary Professor | Dept. Molecular Sciences, Macquarie University
Secretary | Australasian Proteomics Society
Postdoctoral Research Fellow
Postdoctoral Scientist
Matthew McKay - Senior Research Officer
Bharat Venkatesh Gunappa - Research Officer
Atul Bhatnagar - Senior Technical Officer
(Vo Van) Anh Pham - Research Assistant
Miguel Castaneda - Research Affiliate
YuHong Fu - Visiting Researcher
Ping (Wendy) Wu - Visiting Research Assistant
Kiera Hicks - Honours Student
Colby Stevenson - PhD Student
Eve Hopping - Masters Student
Elizabeth Brenchley - Masters student
Current bowel cancer research focuses on:
Our research is facilitated by specimens from clinical projects we run including:
Posted on: 26 July, 2024
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with..... Read more
Category: Funding support, Research Excellence
Posted on: 01 July, 2024
While there has been a great deal of encouraging progress with many cancer treatments over the last ..... Read more
Category: Funding support, Research Excellence
Posted on: 29 May, 2024
Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prest..... Read more
Category: Cardiovascular and Renal Research, Funding support, Research Excellence